Showing results (371-380 of 403) with videos related to

Sort By:
Pageof 41
Neurosurgery|August 30, 2008
Angiographic patterns of Wingspan in-stent restenosisFelipe C Albuquerque, Elad I Levy, Aquilla S Turk, et al.
Journal of the National Cancer Institute|June 1, 2023
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemiaPuja J Umaretiya, Victoria B Koch, Yael Flamand, et al.
Pediatric Blood & Cancer|September 7, 2022
Feasibility of oncology clinical trial-embedded evaluation of social determinants of healthRahela Aziz-Bose, Daniel J Zheng, Puja J Umaretiya, et al.
Neurosurgery|September 6, 2012
Early postmarket results after treatment of intracranial aneurysms with the pipeline embolization device: a U.S. multicenter experiencePeter Kan, Adnan H Siddiqui, Erol Veznedaroglu, et al.
Pediatric Blood & Cancer|August 12, 2024
Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohortRahela Aziz-Bose, Colin Cernik, Puja J Umaretiya, et al.
Pediatric Blood & Cancer|January 11, 2018
Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemiaM L Sulis, T M Blonquist, K E Stevenson, et al.
Pediatric Blood & Cancer|June 8, 2018
Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001Uma H Athale, Maneka Puligandla, Kristen E Stevenson, et al.
Blood Advances|January 26, 2021
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohortSong Yao, Qianqian Zhu, Peter D Cole, et al.
Neurosurgery Practice|April 20, 2026
Patient's Age Impact on Stroke Risk and Intracranial Aneurysm Occlusion: SCENT Flow Diverter Study-A Nonrandomized Clinical Trial on Large and Giant AneurysmsAjay K Wakhloo, Paul Jenkins, Philip M Meyers, et al.
Pediatric Blood & Cancer|March 22, 2022
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001Uma H Athale, Yael Flamand, Traci Blonquist, et al.
Pageof 41